218 related articles for article (PubMed ID: 37601672)
21. Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.
Zhai T; Dou M; Ma Y; Wang H; Liu F; Zhang L; Chong T; Wang Z; Xue L
Lipids Health Dis; 2023 Mar; 22(1):39. PubMed ID: 36915125
[TBL] [Abstract][Full Text] [Related]
22. Detection of microRNA expression levels based on microarray analysis for classification of idiopathic pulmonary fibrosis.
Li Q; Li M; Zheng K; Li H; Yang H; Ma S; Zhong M
Exp Ther Med; 2020 Oct; 20(4):3096-3103. PubMed ID: 32855677
[TBL] [Abstract][Full Text] [Related]
23. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
24. A data-driven biocomputing pipeline with meta-analysis on high throughput transcriptomics to identify genome-wide miRNA markers associated with type 2 diabetes.
De Silva K; Demmer RT; Jönsson D; Mousa A; Forbes A; Enticott J
Heliyon; 2022 Feb; 8(2):e08886. PubMed ID: 35169647
[TBL] [Abstract][Full Text] [Related]
25. Development of an miRNA-Array-Based Diagnostic Signature for Periodontitis.
Jin SH; Zhou JG; Guan XY; Bai GH; Liu JG; Chen LW
Front Genet; 2020; 11():577585. PubMed ID: 33391341
[TBL] [Abstract][Full Text] [Related]
26. A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer.
Bai X; Lu D; Lin Y; Lv Y; He L
Exp Ther Med; 2019 Sep; 18(3):1601-1608. PubMed ID: 31410115
[TBL] [Abstract][Full Text] [Related]
27. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
[TBL] [Abstract][Full Text] [Related]
28. Investigating the change in gene expression profile of blood mononuclear cells post-laparoscopic sleeve gastrectomy in Chinese obese patients.
Liu N; Chen X; Ran J; Yin J; Zhang L; Yang Y; Cen J; Dai H; Zhou J; Gao K; Zhang J; Liu L; Chen Z; Wang H
Front Endocrinol (Lausanne); 2023; 14():1049484. PubMed ID: 36998473
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
30. Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.
Lin Y; Miao Z; Zhang X; Wei X; Hou J; Huang Y; Shen B
Front Genet; 2020; 11():596826. PubMed ID: 33519899
[No Abstract] [Full Text] [Related]
31. Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer.
Wei J; Yang L; Wu YN; Xu J
J Cancer; 2020; 11(6):1325-1333. PubMed ID: 32047539
[No Abstract] [Full Text] [Related]
32. Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm.
Lee J; Lee HS; Park SB; Kim C; Kim K; Jung DE; Song SY
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498271
[TBL] [Abstract][Full Text] [Related]
33. Identification of Critical miRNAs as Novel Diagnostic Markers for Laryngeal Squamous Cell Carcinoma.
Luo K; Zhao Y; Liu H; Mo J
Dis Markers; 2022; 2022():6858411. PubMed ID: 35909889
[TBL] [Abstract][Full Text] [Related]
34. Integrated multiple microarray studies by robust rank aggregation to identify immune-associated biomarkers in Crohn's disease based on three machine learning methods.
Chen ZA; Ma HH; Wang Y; Tian H; Mi JW; Yao DM; Yang CJ
Sci Rep; 2023 Feb; 13(1):2694. PubMed ID: 36792688
[TBL] [Abstract][Full Text] [Related]
35. Identifying Potential miRNA Biomarkers for Gastric Cancer Diagnosis Using Machine Learning Variable Selection Approach.
Gilani N; Arabi Belaghi R; Aftabi Y; Faramarzi E; Edgünlü T; Somi MH
Front Genet; 2021; 12():779455. PubMed ID: 35082831
[No Abstract] [Full Text] [Related]
36. Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now.
Wei L; Yao K; Gan S; Suo Z
Medicine (Baltimore); 2018 Aug; 97(35):e12132. PubMed ID: 30170450
[TBL] [Abstract][Full Text] [Related]
37. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.
Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S
Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652
[TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
39. Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer.
Zhang H; Chen Z; Huang Q; Guo Y; Wang M; Wu C
Cell Oncol (Dordr); 2023 Aug; 46(4):1015-1030. PubMed ID: 36964893
[TBL] [Abstract][Full Text] [Related]
40. Cancer survival classification using integrated data sets and intermediate information.
Kim S; Park T; Kon M
Artif Intell Med; 2014 Sep; 62(1):23-31. PubMed ID: 24997860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
